D3 Bio Investigative Site — New York, New York

D3 Bio Investigative Site is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

D3 Bio Investigative Site has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumors With MAPK Pathway Mutations, HER-2 Positive Advanced Solid Tumors.

Sponsors: D3 Bio (Wuxi) Co., Ltd.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for D3 Bio Investigative Site?

D3 Bio Investigative Site has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has D3 Bio Investigative Site conducted?

D3 Bio Investigative Site has 2 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors With MAPK Pathway Mutations, HER-2 Positive Advanced Solid Tumors.

Is D3 Bio Investigative Site accredited by Crixeo Health?

D3 Bio Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about D3 Bio Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.